Company / Revenue per Share
AYTU BIOPHARMA, INC Revenue per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$11.11
FY2025
5-year range
$3.52 / $55.68
FY2021-FY2025
Trend
-5.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share has fluctuated over the past 10 years, ranging from $0.03 in FY2015 to $88.74 in FY2018.
Based on SEC 10-K filings.
11.11 in FY2025 with a 10-year CAGR of +78.9%.
Declined from $55.68 to $11.11 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +46.8%
- 5-Year CAGR
- +47.8%
- 10-Year CAGR
- +78.9%
Key checks
Key Insights
- In FY2025, revenue per share decreased 5.9% year-over-year.
- Peak revenue per share was recorded in FY2018.
- Lowest revenue per share in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.11 | -5.9% |
| FY2024 | $11.81 | -78.8% |
| FY2023 | $55.68 | +1483.3% |
| FY2022 | $3.52 | -32.6% |
| FY2021 | $5.22 | +231.0% |
| FY2020 | $1.58 | -98.2% |
| FY2018 | $88.74 | +415.4% |
| FY2017 | $17.22 | +698.5% |
| FY2016 | $2.16 | +6408.7% |
| FY2015 | $0.03 | +2964.5% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026